MINNEAPOLIS – August 26, 2019 – TripleTree, LLC, a strategic advisor and merchant bank serving innovative and market-leading companies in healthcare, is pleased to announce that it advised Hospice Partners of America on its pending acquisition by Addus HomeCare. Hospice Partners of America is a multi-state provider of hospice services, leveraging best-in-class clinical practices and operational protocols to provide high-quality care and patient satisfaction.
“Hospice continues to be a large and growing market supported by long-term demographic tailwinds of a rapidly aging population and increasing awareness and utilization of the hospice benefit,” said Jon Hill, Managing Director at TripleTree. “We look forward to Hospice Partners of America and Addus HomeCare joining forces to expand their reach of hospice services across the nation, as they share the same passion for providing high-quality, compassionate healthcare to consumers at home.”
“We have an exciting future ahead with Addus HomeCare. Joining their extensive care network will accelerate our ability to enter new markets and provide hospice services to more patients,” said Norma English, Chief Executive Officer of Hospice Partners of America. “This outcome would not be possible without our partnership with TripleTree. Their deep knowledge and transaction expertise across the post-acute and hospice market helped us identify the right partner to help propel the growth and impact of our hospice platform.”
TripleTree acted as the exclusive financial advisor to Hospice Partners of America for this transaction.
TripleTree is an independent merchant bank focused on mergers and acquisitions, growth capital, recapitalizations, strategic advisory and principal investing. Since 1997, the firm has advised and invested in some of the most innovative, high-growth businesses in healthcare. For more, visit www.triple-tree.com.
About Hospice Partners of America
Hospice Partners of America (HPA) is a multi-state, leading provider of hospice services, leveraging best-in-class clinical practices and operational protocols to provide high-quality care and patient satisfaction. Since its formation in 2010, HPA has demonstrated consistent organic growth coupled with strategic acquisitions and de novo start-ups.